Robert Kotin

Adjunct Professor | Cofounder and Interim CSO
University of Massachusetts Medical School | Longwood Funds Biotech

Robert Kotin has been involved in adeno-associated virus research since 1986 as a post-doctoral fellow at Cornell University Medical College. Most of Kotin’s career was spent as the head of the Laboratory of Molecular Virology and Gene Therapy in the intramural research program in the National Heart, Lung, and Blood Institute of the NIH. During his 20 years in NHLBI, Kotin’s lab focused on the biology and biochemistry of AAV leading to improved and novel recombinant AAV production methodologies. Kotin left the NIH in 2014 to join Voyager Therapeutics and assumed an adjunct professor role at the University of Massachusetts Chan Medical School. Kotin is a scientific co-founder of Generation Bio that uses his lab’s inventions for producing closed-ended linear duplex (CELiD) DNA for non-viral gene therapy.